These studies have examined various clinical and pathological parameters, including patient age, tumour size, tumour type, tumour grade, disease stage, margin status, lymphovascular status, and the status of hormonal receptors (oestrogen and progesterone receptors) and human epidermal growth factor receptor 2 (HER2). This evidence concerns the gene ERBB2 and neoplasm.